Your browser doesn't support javascript.
loading
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
Mill, Christopher P; Fiskus, Warren; DiNardo, Courtney D; Qian, Yimin; Raina, Kanak; Rajapakshe, Kimal; Perera, Dimuthu; Coarfa, Cristian; Kadia, Tapan M; Khoury, Joseph D; Saenz, Dyana T; Saenz, David N; Illendula, Anuradha; Takahashi, Koichi; Kornblau, Steven M; Green, Michael R; Futreal, Andrew P; Bushweller, John H; Crews, Craig M; Bhalla, Kapil N.
Afiliação
  • Mill CP; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Fiskus W; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • DiNardo CD; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Qian Y; Arvinas, Inc., New Haven, CT.
  • Raina K; Arvinas, Inc., New Haven, CT.
  • Rajapakshe K; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
  • Perera D; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
  • Coarfa C; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.
  • Kadia TM; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Khoury JD; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Saenz DT; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Saenz DN; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Illendula A; Department of Molecular Physiology and Biological Physics and Chemistry, University of Virginia, Charlottesville, VA; and.
  • Takahashi K; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Kornblau SM; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Green MR; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Futreal AP; The University of Texas M.D. Anderson Cancer Center, Houston, TX.
  • Bushweller JH; Department of Molecular Physiology and Biological Physics and Chemistry, University of Virginia, Charlottesville, VA; and.
  • Crews CM; Department of Molecular, Cellular, and Developmental Biology.
  • Bhalla KN; Department of Chemistry, and.
Blood ; 134(1): 59-73, 2019 07 04.
Article em En | MEDLINE | ID: mdl-31023702
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Subunidade alfa 2 de Fator de Ligação ao Core / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Subunidade alfa 2 de Fator de Ligação ao Core / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Blood Ano de publicação: 2019 Tipo de documento: Article